CompuGroup Medical SE & Co. KGaA (XETRA:COP) — Stock Price

€22.66 EUR
▲ 0.00% today

CompuGroup Medical SE & Co. KGaA (XETRA:COP) is currently trading at €22.66 EUR, up 0.00% today. Over the past 52 weeks, shares have ranged between €22.66 and €22.66. This page tracks CompuGroup Medical SE & Co. KGaA's live share price on the XETRA exchange, its daily price and volume history, and — where reported — its income statement, balance sheet, cash flow statement, and earnings history. For company valuation and market capitalisation context, see market cap of CompuGroup Medical SE & Co. KGaA.

CompuGroup Medical SE & Co. KGaA (COP) Stock Price Chart — Daily History & Trading Volume

The chart below tracks CompuGroup Medical SE & Co. KGaA's daily closing share price and trading volume on the XETRA exchange over the past year, giving a clear view of recent price momentum and liquidity.

Daily price history is not currently available for CompuGroup Medical SE & Co. KGaA.

CompuGroup Medical SE & Co. KGaA Income Statement — Revenue, Profit & Earnings by Year

CompuGroup Medical SE & Co. KGaA's annual income statement shows how revenue converts into profit each fiscal year, including gross profit, operating income, EBITDA, and net income.

Fiscal Year 20242023202220212020
Total Revenue €1.15 Billion €1.19 Billion €1.13 Billion €1.03 Billion €837.26 Million
Cost of Revenue €188.84 Million €182.61 Million €171.58 Million €739.44 Million €124.31 Million
Gross Profit €965.14 Million €1.01 Billion €958.16 Million €285.89 Million €712.95 Million
Research & Development — €252.16 Million €106.20 Million €123.60 Million €81.80 Million
SG&A €25.30 Million €28.47 Million €33.26 Million €34.01 Million €33.17 Million
Total Operating Expenses €859.40 Million €882.12 Million €850.70 Million €763.29 Million €587.59 Million
Operating Income €105.74 Million €122.93 Million €107.46 Million €108.69 Million €125.37 Million
EBITDA €206.90 Million €215.84 Million €231.36 Million €216.63 Million €192.49 Million
EBIT €95.25 Million €100.04 Million €119.03 Million €105.91 Million €116.88 Million
Interest Expense €33.36 Million €24.34 Million €12.12 Million €8.07 Million €7.58 Million
Income Before Tax €61.89 Million €72.67 Million €106.82 Million €97.87 Million €110.43 Million
Income Tax Expense €27.13 Million €25.80 Million €32.70 Million €28.84 Million €37.01 Million
Net Income €34.60 Million €45.92 Million €73.41 Million €68.97 Million €73.19 Million

CompuGroup Medical SE & Co. KGaA Balance Sheet — Assets, Liabilities & Shareholder Equity

The balance sheet below summarizes CompuGroup Medical SE & Co. KGaA's financial position at each fiscal year-end — what it owns (assets), what it owes (liabilities), and the resulting shareholder equity.

Fiscal Year 20242023202220212020
Total Assets €1.97 Billion €1.90 Billion €1.94 Billion €1.79 Billion €1.57 Billion
Total Current Assets €394.60 Million €369.83 Million €420.81 Million €370.78 Million €308.11 Million
Cash & Equivalents — — — — —
Short-term Investments €427.00K €82.00K €497.00K €340.00K €1.00 Million
Net Receivables €201.56 Million €211.09 Million €221.87 Million €240.56 Million €213.20 Million
Inventory €14.71 Million €18.88 Million €29.44 Million €20.64 Million €18.16 Million
Property, Plant & Equipment — — €160.89 Million €158.00 Million €136.29 Million
Goodwill €735.86 Million €684.10 Million €639.16 Million €588.41 Million €542.45 Million
Total Liabilities €1.32 Billion €1.23 Billion €1.27 Billion €1.18 Billion €926.84 Million
Total Current Liabilities €331.25 Million €346.83 Million €375.47 Million €398.35 Million €290.54 Million
Long-term Debt €794.46 Million €704.25 Million €699.42 Million €17.75 Billion €470.20 Million
Net Debt €772.81 Million €702.48 Million €696.00 Million €634.02 Million €479.93 Million
Total Stockholder Equity €647.91 Million €667.68 Million €672.42 Million €612.07 Million €638.67 Million
Retained Earnings — — — €40.67 Billion €35.21 Billion

CompuGroup Medical SE & Co. KGaA Cash Flow Statement — Operating, Investing & Financing Activities

This cash flow statement breaks down how CompuGroup Medical SE & Co. KGaA generates and spends cash across operating, investing, and financing activities each fiscal year, including free cash flow and capital expenditures.

Fiscal Year 20242023202220212020
Operating Cash Flow €128.88 Million €179.53 Million €145.03 Million €165.27 Million €149.93 Million
Capital Expenditures €63.23 Million €75.41 Million €81.04 Million €77.50 Million €55.73 Million
Free Cash Flow €65.66 Million €104.11 Million €63.99 Million €87.78 Million €94.20 Million
Investing Cash Flow €-105.28 Million €-124.33 Million €-145.41 Million €-163.98 Million €-457.12 Million
Financing Cash Flow €18.81 Million €-80.69 Million €-16.36 Million €30.15 Million €338.07 Million
Dividends Paid €51.73 Million €26.12 Million €26.12 Million €26.37 Million €24.21 Million
Stock-Based Compensation — €-7.04 Million €2.64 Million €5.72 Million €5.88 Million
Depreciation €111.65 Million €115.80 Million €112.32 Million €110.71 Million €75.71 Million
Change in Cash €42.87 Million €-26.06 Million €-16.83 Million €31.43 Million €29.56 Million

CompuGroup Medical SE & Co. KGaA Earnings History — EPS Actual vs. Analyst Estimates

Track CompuGroup Medical SE & Co. KGaA's quarterly earnings per share (EPS) against Wall Street estimates, along with the earnings surprise percentage for each reporting period.

Report Date EPS Actual EPS Estimate Surprise
Apr 28, 2026 — — —
Nov 05, 2025 — — —
Jul 31, 2025 — — —
Apr 30, 2025 0.35 0.41 -14.63%
Mar 26, 2025 0.11 0.39 -71.79%
Nov 07, 2024 0.35 0.30 +16.67%
Jul 15, 2024 0.27 0.50 -46.14%
May 08, 2024 0.47 0.38 +23.68%